Evidence map›Paper›PMID 34680857›Full record

ArticleGenes2021

Differential Diagnosis between Marfan Syndrome and Loeys-Dietz Syndrome Type 4: A Novel Chromosomal Deletion Covering TGFB2.

Stefano Nistri, Rosina De Cario, Elena Sticchi, Gaia Spaziani, Matteo Della Monica, Sabrina Giglio, Silvia Favilli, Betti Giusti, Pierluigi Stefano, Guglielmina Pepe

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Human DNA Mutations and their Impact on Genetic Disorders.Recent patents on biotechnology · 2024
    Review
  5. Bifid Uvula-An Enigma.Journal of pharmacy & bioallied sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Stefano NistriCMSR Veneto Medica-Cardiology Service, 36077 Altavilla Vicentina, Italy.
Rosina De CarioDepartment of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Elena SticchiDepartment of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Gaia SpazianiPediatric Cardiology, Azienda Ospedaliera Universitaria Meyer, 50139 Florence, Italy.ORCID 0000-0002-4697-6303
Matteo Della MonicaMedical Genetics Unit, Cardarelli Hospital, 80131 Napoli, Italy.
Sabrina GiglioUnit of Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, 09024 Cagliari, Italy.ORCID 0000-0002-3954-326X
Silvia FavilliPediatric Cardiology, Azienda Ospedaliera Universitaria Meyer, 50139 Florence, Italy.ORCID 0000-0003-3006-6513
Betti GiustiDepartment of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Pierluigi StefanoDepartment of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.ORCID 0000-0001-8338-3016
Guglielmina PepeDepartment of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.ORCID 0000-0001-9825-6618
University of Florence · ITMeyer Children's Hospital · ITAzienda Ospedaliero-Universitaria Careggi · ITUniversity of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marfan syndrome (MFS) and Loeys-Dietz syndrome type 4 (LDS4) are two hereditary connective tissue disorders. MFS displays ectopia lentis as a distinguishing, characterising feature, and thoracic aortic ectasia, aneurysm, dissection, and systemic features as manifestations overlapping with LDS4. LDS4 is characterised by the presence of hypertelorism, cleft palate and/or bifid uvula, with possible ectasia or aneurysms in other arteries. The variable age of onset of clinical manifestations makes clinical diagnosis more difficult. In this study, we report the case of a patient with Marfan syndrome diagnosed at our centre at the age of 33 on the basis of typical clinical manifestations of this syndrome. At the age of 38, the appearance of ectasia of the left common iliac artery and tortuosity of the iliac arteries suggested the presence of LDS4. Next Generation Sequencing (NGS) analysis, followed by Array-CGH, allowed the detection of a novel chromosomal deletion including the entire TGFB2 gene, confirming not only the clinical suspicion of LDS4, but also the clinical phenotype associated with the haploinsufficiency mechanism, which is, in turn, associated with the deletion of the entire gene. The same mutation was detected in the two young sons. This emblematic case confirms that we must be very careful in the differential diagnosis of these two pathologies, especially before the age of 40, and that, in young subjects suspected to be affected by MFS in particular, we must verify the diagnosis, extending genetic analysis, when necessary, to the search for chromosomal alterations. Recently, ectopia lentis has been reported in a patient with LDS4, confirming the tight overlap between the two syndromes. An accurate revision of the clinical parameters both characterising and overlapping the two pathologies is highly desirable.

Indexed as

Chromosome DeletionDiagnosis, DifferentialFemaleHumansLoeys-Dietz SyndromeMaleMarfan SyndromePedigreeTransforming Growth Factor beta2TGFB2 protein, humanTransforming Growth Factor beta2chromosomal microdeletionFBN1hereditary thoracic aortic aneurysms and dissectionsLDS type 4Loeys–Dietz syndromeMarfan syndromeSMAD3TGFB2TGFB3TGFBR1TGFBR2

Identifiers

PMID34680857
PMCPMC8536070
OpenAlexW3202161827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.